Compounds of diphenylcyclopentylamine type and methods for their

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2605011, 26050112, 26050118, 26050119, 26050121, 260515R, 260544N, 260558R, 260570R, 260571, 260576, 260578, 260590C, 424316, A01N 920, A01N 924

Patent

active

040536378

ABSTRACT:
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein X and Y are the same or different and each representing a hydrogen atom, a chloro or a methoxy group, n is an integer 0 or 1 and R.sup.1 and R.sup.2 are the same or different and each representing a hydrogen atom or a methyl group; processes for their preparation; pharmaceutical preparations containing at least one of these compounds and the use thereof in the treatment of depressive states.

REFERENCES:
patent: 3285960 (1966-11-01), Halverstadt
patent: 3328249 (1967-06-01), Aceto et al.
patent: 3376312 (1968-04-01), Unger et al.
Graham et al., "Journal of the Chemical Society" of London, p. 390 (1969).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds of diphenylcyclopentylamine type and methods for their does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds of diphenylcyclopentylamine type and methods for their, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds of diphenylcyclopentylamine type and methods for their will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-739942

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.